Edition:
United Kingdom

Glenmark Pharmaceuticals Ltd (GLEN.NS)

GLEN.NS on National Stock Exchange of India

537.50INR
10:22am GMT
Change (% chg)

Rs0.35 (+0.07%)
Prev Close
Rs537.15
Open
Rs537.00
Day's High
Rs543.95
Day's Low
Rs525.85
Volume
708,471
Avg. Vol
952,715
52-wk High
Rs972.95
52-wk Low
Rs525.85

Latest Key Developments (Source: Significant Developments)

Glenmark Pharmaceuticals Meets Primary Clinical Endpoint In Phase 3 Study Of Ryaltris
Thursday, 14 Dec 2017 

Dec 14 (Reuters) - Glenmark Pharmaceuticals Ltd ::SAYS MET ITS PRIMARY CLINICAL ENDPOINT IN A PHASE 3 STUDY EVALUATING SAFETY OF RYALTRIS.SAYS RYALTRIS IS AN INVESTIGATIONAL FIXED-DOSE COMBINATION NASAL SPRAY, IN PERENNIAL ALLERGIC RHINITIS.TO FILE FIRST NDA TO US FDA FOR RYALTRIS IN THE FIRST QUARTER OF CY 2018.  Full Article

Glenmark Pharma Says Closed DCP For Generic Seretide Accuhaler In Nordic Region​
Friday, 1 Dec 2017 

Dec 1 (Reuters) - Glenmark Pharmaceuticals Ltd ::ANNOUNCES CLOSURE OF DECENTRALISED REGISTRATION PROCEDURE (DCP) FOR GENERIC SERETIDE ACCUHALER IN NORDIC REGION​.  Full Article

Glenmark Pharma Says U.S. FDA issues 7 Form 483 observations for co's ‍Baddi Unit
Tuesday, 28 Nov 2017 

Nov 28 (Reuters) - Glenmark Pharmaceuticals Ltd ::GLENMARK PHARMACEUTICALS SAYS ‍BADDI UNIT UNDERWENT AN U.S. FDA AUDIT FROM NOVEMBER 6, 2017 TO NOVEMBER 11, 2017.GLENMARK PHARMACEUTICALS LTD <<>> SAYS ‍U.S. FDA ISSUED 7 OBSERVATIONS VIA FORM 483​​.  Full Article

Glenmark Pharmaceuticals gets ANDA approval for HAILEY Fe 1/20 tablets ​
Wednesday, 22 Nov 2017 

Nov 22 (Reuters) - Glenmark Pharmaceuticals Ltd :Gets ANDA approval for HAILEY Fe 1/20 tablets ​.  Full Article

Glenmark Pharmaceuticals gets ANDA approval for Haileytm 24 FE 1 mg/20 mcg​
Monday, 20 Nov 2017 

Nov 20 (Reuters) - Glenmark Pharmaceuticals Ltd :Gets ANDA approval for Haileytm 24 fe 1 mg/20 mcg​.  Full Article

India's Glenmark Pharmaceuticals Sept-qtr consol profit falls about 4 pct
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - Glenmark Pharmaceuticals Ltd :Sept quarter consol profit 2.14 billion rupees versus profit of 2.24 billion rupees last year.Consensus forecast for Sept quarter consol profit was 2.10 billion rupees.Sept quarter consol net sales 22.23 billion rupees versus 21.73 billion rupees last year.  Full Article

Glenmark Pharmaceuticals gets ANDA approval for aprepitant capsules USP​
Monday, 16 Oct 2017 

Oct 16 (Reuters) - Glenmark Pharmaceuticals Ltd :Says ‍Glenmark Pharmaceuticals receives ANDA approval for aprepitant capsules USP​.  Full Article

Glenmark Pharmaceuticals gets ANDA approval for propafenone hydrochloride extended-release capsules USP
Monday, 11 Sep 2017 

Sept 11 (Reuters) - Glenmark Pharmaceuticals :Says co receives ANDA approval for propafenone hydrochloride extended-release capsules USP, 225 mg, 325 mg, and 425 mg.  Full Article

Glenmark Pharmaceuticals gets ANDA approval for ointment to treat skin inflammation
Wednesday, 23 Aug 2017 

Aug 23 (Reuters) - Glenmark Pharmaceuticals Ltd :Says receives ANDA approval for triamcinolone acetonide ointment usp, 0.1%.  Full Article

Glenmark Pharmaceuticals licenses small molecule oncology compound from APC Therapeutics
Wednesday, 21 Jun 2017 

June 21 (Reuters) - Glenmark Pharmaceuticals Ltd :Says entered into a licensing agreement with boston-based APC Therapeutics Inc.Says licenses small molecule oncology compound from APC Therapeutics to expand immuno-oncology portfolio.Compound has potential to be used as a monotherapy or in combination with approved therapies to address unmet needs in cancer treatment..Co will license product from apc therapeutics, manage clinical development including regulatory filings & commercialization worldwide.APC Therapeutics will receive development milestones and sales royalty payments..  Full Article